相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabolic and Metabolomics Insights into Dilated Cardiomyopathy
Isaac Ampong
ANNALS OF NUTRITION AND METABOLISM (2022)
Relaxin as an anti-fibrotic treatment: Perspectives, challenges and future directions
Chrishan S. Samuel et al.
BIOCHEMICAL PHARMACOLOGY (2022)
Relaxin Inhibits the Cardiac Myofibroblast NLRP3 Inflammasome as Part of Its Anti-Fibrotic Actions via the Angiotensin Type 2 and ATP (P2X7) Receptors
Felipe Tapia Caceres et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)
Simultaneous targeting of oxidative stress and fibrosis reverses cardiomyopathy-induced ventricular remodelling and dysfunction
Chao Wang et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
Assessment of renal fibrosis and anti-fibrotic agents using a novel diagnostic and stain-free second-harmonic generation platform
Sadman Bhuiyan et al.
FASEB JOURNAL (2021)
Relaxin Attenuates Organ Fibrosis via an Angiotensin Type 2 Receptor Mechanism in Aged Hypertensive Female Rats
Giannie Barsha et al.
KIDNEY360 (2021)
Recombinant human H2 relaxin (serelaxin) as a cardiovascular drug: aiming at the right target
Daniele Bani
DRUG DISCOVERY TODAY (2020)
B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice
Teja Devarakonda et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Chronic stress and endothelial dysfunction: mechanisms, experimental challenges, and the way ahead
Lucien Derek Sher et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
Serelaxin and the AT2 Receptor Agonist CGP42112 Evoked a Similar, Nonadditive, Cardiac Antifibrotic Effect in High Salt-Fed Mice That Were Refractory to Candesartan Cilexetil
Yan Wang et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
AT1R-AT2R-RXFP1 Functional Crosstalk in Myofibroblasts: Impact on the Therapeutic Targeting of Renal and Cardiac Fibrosis
Bryna S. M. Chow et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)
Effects of Serelaxin in Patients with Acute Heart Failure
Marco Metra et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Single chain peptide agonists of relaxin receptors
Praveen Praveen et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Relaxin-2 for heart failure with preserved ejection fraction (HFpEF): Rationale for future clinical trials
Thomas Bernd Dschietzig
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
Cardioprotective actions of relaxin
Brian Martin et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2019)
The actions of relaxin on the human cardiovascular system
Mohsin Sarwar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
B7-33 replicates the vasoprotective functions of human relaxin-2 (serelaxin)
Sarah A. Marshall et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2017)
ML290 is a biased allosteric agonist at the relaxin receptor RXFP1
Martina Kocan et al.
SCIENTIFIC REPORTS (2017)
Serelaxin in clinical development: past, present and future
Elaine Unemori
BRITISH JOURNAL OF PHARMACOLOGY (2017)
SINGLE-CHAIN DERIVATIVE OF THE RELAXIN HORMONE IS A FUNCTIONALLY SELECTIVE AGONIST OF THE G PROTEIN-COUPLED RECEPTOR,RXFP1
M. A. Hossain et al.
JOURNAL OF PEPTIDE SCIENCE (2016)
The Anti-fibrotic Actions of Relaxin Are Mediated Through a NO-sGC-cGMP-Dependent Pathway in Renal Myofibroblasts In Vitro and Enhanced by the NO Donor, Diethylamine NONOate
Chao Wang et al.
FRONTIERS IN PHARMACOLOGY (2016)
The Effects of Rilmenidine and Perindopril on Arousal Blood Pressure during 24 Hour Recordings in SHR
Kyungjoon Lim et al.
PLoS One (2016)
A single-chain derivative of the relaxin hormone is a functionally selective agonist of the G protein-coupled receptor, RXFP1
Mohammed Akhter Hossain et al.
CHEMICAL SCIENCE (2016)
Serelaxin-mediated signal transduction in human vascular cells: bell-shaped concentration-response curves reflect differential coupling to G proteins
M. Sarwar et al.
BRITISH JOURNAL OF PHARMACOLOGY (2015)
Relaxin Activates Peroxisome Proliferator-activated Receptor γ (PPARγ) through a Pathway Involving PPARγ Coactivator 1α ( PGC1α)
Sudhir Singh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Crosstalk between fibroblasts and inflammatory cells
Sophie Van Linthout et al.
CARDIOVASCULAR RESEARCH (2014)
Synthetic relaxins
Mohammed Akhter Hossain et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2014)
Serelaxin Is a More Efficacious Antifibrotic Than Enalapril in an Experimental Model of Heart Disease
Chrishan S. Samuel et al.
HYPERTENSION (2014)
Relaxin requires the angiotensin II type 2 receptor to abrogate renal interstitial fibrosis
Bryna S. Man Chow et al.
KIDNEY INTERNATIONAL (2014)
Relaxin decreases the severity of established hepatic fibrosis in mice
Robert G. Bennett et al.
LIVER INTERNATIONAL (2014)
Hydrogen sulfide protects endothelial nitric oxide function under conditions of acute oxidative stress in vitro.
Mohammad R. Al-Magableh et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
Isoproterenol Induces Vascular Oxidative Stress and Endothelial Dysfunction via a Giα-Coupled β2-Adrenoceptor Signaling Pathway
Ana P. Davel et al.
PLOS ONE (2014)
Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program Correlation With Outcomes
Marco Metra et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
John R. Teerlink et al.
LANCET (2013)
RELAXIN FAMILY PEPTIDES AND THEIR RECEPTORS
R. A. D. Bathgate et al.
PHYSIOLOGICAL REVIEWS (2013)
A randomized, placebo-controlled clinical trial on the effects of recombinant human relaxin on tooth movement and short-term stability
Susan P. McGorray et al.
AMERICAN JOURNAL OF ORTHODONTICS AND DENTOFACIAL ORTHOPEDICS (2012)
Relaxin Signals through a RXFP1-pERK-nNOS-NO-cGMP-Dependent Pathway to Up-Regulate Matrix Metalloproteinases: The Additional Involvement of iNOS
Bryna Suet Man Chow et al.
PLOS ONE (2012)
Effects of Relaxin on Arterial Dilation, Remodeling, and Mechanical Properties
Kirk P. Conrad et al.
CURRENT HYPERTENSION REPORTS (2011)
Relaxin Induces Rapid Dilation of Rodent Small Renal and Human Subcutaneous Arteries via PI3 Kinase and Nitric Oxide
Jonathan T. McGuane et al.
ENDOCRINOLOGY (2011)
The Minimal Active Structure of Human Relaxin-2
Mohammed Akhter Hossain et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Influence of genetic background on ex vivo and in vivo cardiac function in several commonly used inbred mouse strains
Matthew S. Barnabei et al.
PHYSIOLOGICAL GENOMICS (2010)
Recombinant Human Relaxin in the Treatment of Systemic Sclerosis With Diffuse Cutaneous Involvement A Randomized, Double-Blind, Placebo-Controlled Trial
Dinesh Khanna et al.
ARTHRITIS AND RHEUMATISM (2009)
Relaxin inhibits renal myofibroblast differentiation via RXFP1, the nitric oxide pathway, and Smad2
Ishanee Mookerjee et al.
FASEB JOURNAL (2009)
Relaxin, a pleiotropic vasodilator for the treatment of heart failure
Sam L. Teichman et al.
HEART FAILURE REVIEWS (2009)
A novel approach to improve cardiac performance: cardiac myosin activators
John R. Teerlink
HEART FAILURE REVIEWS (2009)
Higher levels of collagen and facilitated healing protect against ventricular rupture following myocardial infarction
Lu Fang et al.
CLINICAL SCIENCE (2008)
Fenofibrate and Pioglitazone Do Not Ameliorate the Altered Vascular Reactivity in Aorta of Isoproterenol-treated Rats
Livia Emy Fukuda et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Chronic angiotensin IV treatment reverses endothelial dysfunction in ApoE-deficient mice
Antony Vinh et al.
CARDIOVASCULAR RESEARCH (2008)
Paracrine effects of transplanted myoblasts and relaxin on post-infarction heart remodelling
Lucia Formigli et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2007)
Changes in vascular reactivity following administration of isoproterenol for 1 week: a role for endothelial modulation
Ana Paula C. Davel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2006)
Altered vascular reactivity in mice made hypertensive by nitric oxide synthase inhibition
AE Linder et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2005)
Enhanced vascular reactivity of small mesenteric arteries from diabetic mice is associated with enhanced oxidative stress and cyclooxygenase products
M Pannirselvam et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Cardioprotective action of perindopril versus candesartan in renovascular hypertensive rats
M Nagai et al.
CARDIOVASCULAR DRUGS AND THERAPY (2004)
Myogenic reactivity is reduced in small renal arteries isolated from relaxin-treated rats
J Novak et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2002)
Cellular basis of endothelial dysfunction in small mesenteric arteries from spontaneously diabetic (db/db-/-) mice:: role of decreased tetrahydrobiopterin bioavailability
M Pannirselvam et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
The pregnancy hormone relaxin is a player in human heart failure
T Dschietzig et al.
FASEB JOURNAL (2001)
分享论文
